Prognosis
Johnson & Johnson’s Single-Shot Covid Vaccine Approved by EU
- European Commission follows drug regulator in clearing vaccine
- J&J shot seen as easier to distribute, administer than rivals
This article is for subscribers only.
Johnson & Johnson’s coronavirus vaccine won clearance from the European Union, adding the first single-dose shot to the bloc’s arsenal as it seeks to speed up a sluggish immunization campaign.
The European Commission granted a conditional marketing authorization after the EU’s drugs regulator recommended approval for all adults earlier Thursday. It’s the fourth shot to be cleared in the region after those made by AstraZeneca Plc and the University of Oxford, Pfizer Inc. and partner BioNTech SE, and Moderna Inc.